Prolonged-release fampridine for the treatment of myoclonus after cervical myelitis: a case report

Prolonged-release fampridine (PR-FAM), a potassium channel blocker, is approved for improving walking ability in patients with multiple sclerosis (MS). Beyond this, positive effects on other MS symptoms like fatigue, cognition, and tremor have been described. To our knowledge, a positive effect of P...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Mona Klara Ros, Christ, Monika, Naumann, Markus, Bayas, Antonios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968993/
https://www.ncbi.nlm.nih.gov/pubmed/35371294
http://dx.doi.org/10.1177/17562864221083608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968993/
https://www.ncbi.nlm.nih.gov/pubmed/35371294
http://dx.doi.org/10.1177/17562864221083608

Ejemplares similares